Literature DB >> 6818245

Phenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains.

B K Pugashetti, H M Metzger, L Vadas, D S Feingold.   

Abstract

Mucoid strains of Pseudomonas aeruginosa isolated from patients with cystic fibrosis or urinary tract infections displayed many phenotypic differences. The ratios of D-mannuronosyl to L-guluronosyl moieties of the extracellular alginate-like polysaccharides produced by the 19 strains examined varied from 99 to 0.8; the acetyl content of the polymers varied from 0.38 to 0.02 mol per mole of uronosyl residue. The strains also differed with regard to the stability of the mucoid phenotype. Of 15 isolates from patients with cystic fibrosis, 7 displayed stable mucoid phenotypes; 8 isolates were unstable and reverted to the nonmucoid phenotype at high frequency. The four strains isolated from patients with urinary tract infections were also unstable. Strains from urinary tract infections expressed the mucoid phenotype on six different media, both minimal and complex, whereas cystic fibrosis-associated strains varied widely with regard to medium-dependent expression of the mucoid phenotype. Of 15 cystic fibrosis strains, 5 were mucoid on each of six different media, 4 were mucoid on five media, 1 was mucoid on four media, 4 were mucoid on three media, and 1 yielded mucoid colonies on only one of the six media tested. There was no obvious correlation among polysaccharide structure, stability of the mucoid phenotype, and medium-dependent expression of the mucoid phenotype for any of the 19 strains investigated. These data suggest that although mucoid strains of P. aeruginosa must share some common property related to their ability to colonize their host, this property seems to be unrelated to polysaccharide composition, medium-dependent expression of the mucoid phenotype, or stability of the mucoid phenotype.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6818245      PMCID: PMC272446          DOI: 10.1128/jcm.16.4.686-691.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Pyocine typing of mucoid strains of Pseudomonas aeruginosa isolated from children with cystic fibrosis.

Authors:  R J Williams; J R Govan
Journal:  J Med Microbiol       Date:  1973-08       Impact factor: 2.472

2.  Mucoid variation in Pseudomonas aeruginosa induced by the action of phage.

Authors:  D R Martin
Journal:  J Med Microbiol       Date:  1973-02       Impact factor: 2.472

3.  Increasing incidence of encapsulated Pseudomonas aeruginosa strains.

Authors:  H R Elston; K C Hoffman
Journal:  Am J Clin Pathol       Date:  1967-11       Impact factor: 2.493

4.  Polyuronic acids produced by Pseudomonas aeruginosa.

Authors:  D M Carlson; L W Matthews
Journal:  Biochemistry       Date:  1966-09       Impact factor: 3.162

5.  Mucoid Pseudomonas aeruginosa in patients with chronic illnesses.

Authors:  R G Doggett; G M Harrison; R E Carter
Journal:  Lancet       Date:  1971-01-30       Impact factor: 79.321

6.  Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.

Authors:  E Diaz; L L Mosovich; E Neter
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

7.  Incidence of mucoid Pseudomonas aeruginosa from clinical sources.

Authors:  R G Doggett
Journal:  Appl Microbiol       Date:  1969-11

8.  A new polysaccharide resembling alginic acid isolated from pseudomonads.

Authors:  A Linker; R S Jones
Journal:  J Biol Chem       Date:  1966-08-25       Impact factor: 5.157

9.  Dissociation in Pseudomonas aeruginosa.

Authors:  C H Zierdt; P J Schmidt
Journal:  J Bacteriol       Date:  1964-05       Impact factor: 3.490

10.  Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.

Authors:  L R Evans; A Linker
Journal:  J Bacteriol       Date:  1973-11       Impact factor: 3.490

View more
  19 in total

1.  Use of slime dispersants to promote antibiotic penetration through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa.

Authors:  C A Gordon; N A Hodges; C Marriott
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

2.  Alginate production by plant-pathogenic pseudomonads.

Authors:  W F Fett; S F Osman; M L Fishman; T S Siebles
Journal:  Appl Environ Microbiol       Date:  1986-09       Impact factor: 4.792

3.  Co-evolution with lytic phage selects for the mucoid phenotype of Pseudomonas fluorescens SBW25.

Authors:  Pauline Deirdre Scanlan; Angus Buckling
Journal:  ISME J       Date:  2011-12-22       Impact factor: 10.302

4.  Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  J Cyst Fibros       Date:  2019-04-26       Impact factor: 5.482

Review 5.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

6.  Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa.

Authors:  Aaron M Firoved; Vojo Deretic
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

7.  Isolation and characterization of an alginase from mucoid strains of Pseudomonas aeruginosa.

Authors:  A Linker; L R Evans
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490

Review 8.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

9.  Interaction of a rat lung lectin with the exopolysaccharides of Pseudomonas aeruginosa.

Authors:  H A McArthur; H Ceri
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

Review 10.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.